id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-2687	Conforti, Claudio; Dell'aquila, Carmen; Tognetto, Daniele; Zalaudek, Iris ; di Meo, Nicola	Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects?	2023	2	.pdf	application/pdf	1055	77	61	Based on the data suggesting a good response of LM to topical treatment with IMQ 5%, it was started five days per week. Therefore, considering the benefits of IMQ and the absence of permanent ocular side effects, the use of IMQ in the perio- cular area should not be avoided for fear of conjunctival inflammation which, if it occurs, can be treated, and pre- vented with topical therapy.	cache/dpc-2687.pdf	txt/dpc-2687.txt